Alpha 2.0
Login Register
» Authors » Stephanie Kremp

Stephanie Kremp

Explore the profile of Stephanie Kremp including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 533
Followers 0
Related Specialties
Radiology
Oncology
Nuclear Medicine
Top 10 Co-Authors
Christian Rube
Jochen Fleckenstein
Ursula Nestle
Carl-Martin Kirsch
Andrea Schaefer-Schuler
Dirk Hellwig
Aleksandar Grgic
Tanja Schimek-Jasch
Anca-Ligia Grosu
Matthias Miederer
Published In
Eur J Nucl Med Mol Imaging
J Nucl Med
Int J Radiat Oncol Biol Phys
PLoS One
Radiother Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial
Craddock M, Nestle U, Koenig J, Schimek-Jasch T, Kremp S, Lenz S, et al.
J Thorac Oncol . 2022 Sep; 18(1):57-66. PMID: 36130693
Introduction: Heart dose has emerged as an independent predictor of overall survival in patients with NSCLC treated with radiotherapy. Several studies have identified the base of the heart as a...
2.
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial
Gkika E, Schimek-Jasch T, Kremp S, Lenz S, Stockinger M, Schaefer-Schuler A, et al.
Radiother Oncol . 2021 Jul; 163:32-38. PMID: 34311004
Introduction: The success of intensification and personalisation of the curative treatment of non-small cell lung cancer (NSCLC) is strongly associated with the precision in radiotherapy. Here, we evaluate the impact...
3.
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial
Gkika E, Lenz S, Schimek-Jasch T, Waller C, Kremp S, Schaefer-Schuler A, et al.
Cancers (Basel) . 2020 Nov; 12(11). PMID: 33202825
(1) Background: The optimal chemotherapy (CHT) regimen for concurrent chemoradiation (cCRT) is not well defined. In this secondary analysis of the international randomized PET-Plan trial, we evaluate the efficacy of...
4.
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Kusters A, et al.
Lancet Oncol . 2020 Mar; 21(4):581-592. PMID: 32171429
Background: With increasingly precise radiotherapy and advanced medical imaging, the concept of radiotherapy target volume planning might be redefined with the aim of improving outcomes. We aimed to investigate whether...
5.
Magnetic Resonance Lymphography at 9.4 T Using a Gadolinium-Based Nanoparticle in Rats: Investigations in Healthy Animals and in a Hindlimb Lymphedema Model
Muller A, Fries P, Jelvani B, Lux F, Rube C, Kremp S, et al.
Invest Radiol . 2017 Jul; 52(12):725-733. PMID: 28678084
Objectives: Magnetic resonance lymphography (MRL) in small animals is a promising but challenging tool in preclinical lymphatic research. In this study, we compared the gadolinium (Gd)-based nanoparticle AGuIX with Gd-DOTA...
6.
The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer
Fleckenstein J, Jelden M, Kremp S, Jagoda P, Stroeder J, Khreish F, et al.
PLoS One . 2016 Sep; 11(9):e0162816. PMID: 27612171
Objective: The study was designed to evaluate diffusion-weighted magnetic resonance imaging (DWI) vs. PET-CT of the thorax in the determination of gross tumor volume (GTV) in radiotherapy planning of non-small-cell...
7.
IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning
Fleckenstein J, Kremp K, Kremp S, Palm J, Rube C
Strahlenther Onkol . 2015 Oct; 192(2):75-82. PMID: 26438071
Aim: The potential of intensity-modulated radiation therapy (IMRT) as opposed to three-dimensional conformal radiotherapy (3D-CRT) is analyzed for two different concepts of fluorodeoxyglucose positron emission tomography (FDG PET)-based target volume...
8.
Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
Fleckenstein J, Eschler A, Kremp K, Kremp S, Rube C
Radiat Oncol . 2015 Aug; 10:178. PMID: 26292716
Background: The advent of IMRT and image-guided radiotherapy (IGRT) in combination with involved-field radiotherapy (IF-RT) in inoperable non-small-cell lung cancer results in a decreased incidental dose deposition in elective nodal...
9.
Commissioning and first clinical application of mARC treatment
Dzierma Y, Nuesken F, Kremp S, Palm J, Licht N, Rube C
Strahlenther Onkol . 2014 Apr; 190(11):1046-52. PMID: 24777584
Background: The modulated arc (mARC) technique has recently been introduced for Siemens ARTISTE linear accelerators. We present the first experiences with the commissioning of the system and first patient treatments....
10.
PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings
Schaefer A, Kim Y, Kremp S, Mai S, Fleckenstein J, Bohnenberger H, et al.
Eur J Nucl Med Mol Imaging . 2013 May; 40(8):1233-44. PMID: 23632957
Purpose: The objective of the study was to validate an adaptive, contrast-oriented thresholding algorithm (COA) for tumour delineation in (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for non-small cell lung cancer...